UTHealth Houston Joins Saturn Trial, Studying Role of Statins in Recurrent Intracerebral Hemorrhage
August 12, 2023
August 12, 2023
HOUSTON, Texas, Aug. 12 (TNSres) -- The University of Texas Health Science Center at Houston issued the following news:
By Caitie Barkley
A clinical trial evaluating the role of statins in the risk of recurrent intracerebral hemorrhage (ICH) in patients presenting with ICH, has opened for enrollment at UTHealth Houston.
The study, led locally by C.J. Jared Chen, MD, assistant professor in the Vivian L. Smith Department of Neurosurgery with McGovern Medical . . .
By Caitie Barkley
A clinical trial evaluating the role of statins in the risk of recurrent intracerebral hemorrhage (ICH) in patients presenting with ICH, has opened for enrollment at UTHealth Houston.
The study, led locally by C.J. Jared Chen, MD, assistant professor in the Vivian L. Smith Department of Neurosurgery with McGovern Medical . . .